GPO Plus (OTCQB:GPOX) could be a rising star in the health care industry

Inflation is back. It’s back in a major way. The consumer price index for all items rose 0.6% in January, driving up annual inflation by 7.5%. That marked the biggest gain since February 1982 and was even higher than the Wall Street estimate. (3) It’s taking its toll on everyone from manufacturers to businesses to […]

United Therapeutics Down 15% Following FDA’s Rejection of Oral Remodulin (UTHR)

After the close of trading yesterday, biopharmaceutical company United Therapeutics (NASDAQ: UTHR) disclosed that its New Drug Application for an oral version of its lung disorder drug, Remodulin, was rejected by the FDA citing an inability to demonstrate patient improvement in Phase III studies. With such negative news, traders had no second thought and went […]

Lexicon Pharmaceutical’s Stock Actively Traded After Releasing New Carcinoid Treatment Drug Data (LXRX)

Lexicon Pharmaceuticals (NASDAQ: LXRX) shares saw a dramatic rise in volume after releasing new tumor drug data. On Friday, the company released new information and clinical data about its proposed drug Telotristat. Lexicon is developing Telotristat as a treatment option for a carcinogenic condition created by tumors in the gastrointestinal tract. This carcinoid syndrome affects […]